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Virulence gene expression in Vibrio cholerae is dependent upon a complex transcriptional cascade that is
influenced by both specific and global regulators in response to environmental stimuli. Here, we report that the
global regulator integration host factor (IHF) positively affects virulence gene expression in V. cholerae.
Inactivation of ihfA and ihfB, the genes encoding the IHF subunits, decreased the expression levels of the two
main virulence factors tcpA and ctx and prevented toxin-coregulated pilus and cholera toxin production. IHF
was found to directly bind to and bend the tcpA promoter region at an IHF consensus site centered at position
ⴚ162 by using gel mobility shift assays and DNase I footprinting experiments. Deletion or mutation of the tcpA
IHF consensus site resulted in the loss of IHF binding and additionally disrupted the binding of the repressor
H-NS. DNase I footprinting revealed that H-NS protection overlaps with both the IHF and the ToxT binding
sites at the tcpA promoter. In addition, disruption of ihfA in an hns or toxT mutant background had no effect
on tcpA expression. These results suggest that IHF may function at the tcpA promoter to alleviate H-NS
repression.

H-NS dimers bind to nucleating high-affinity sites, corresponding with the identified 10-bp consensus motif TCGATAAATT,
located within AT-rich regions, and polymerize outward along
the DNA, eventually resulting in the condensation of DNA
through the formation of protein bridges between H-NS binding sites (4, 29). This DNA remodeling can directly interfere
with RNA polymerase action or block the binding of specific
activators at a nearby promoter region.
IHF is a heterodimeric protein composed of the subunits
IHF␣ (11.3 kDa) and IHF␤ (10.6 kDa), encoded by the ihfA
(himA) and ihfB (hipB) genes, respectively. The two subunits
have approximately 35% identity to each other. Unlike H-NS,
IHF recognizes a specific asymmetric site on DNA, the 13-bp
consensus target sequence WATCAANNNNTTR, where W
represents A or T and R represents A or G (10). Upon binding,
IHF is known to bend DNA by as much as 180° (48, 61). In E.
coli and S. enterica serovar Typhimurium, IHF is involved in
controlling the transcriptions of over 100 genes of various
functions (2, 33, 35). In addition, IHF has increasingly been
identified as a regulator of virulence gene expression in various
pathogens. IHF is required for appropriate expression of the
Brucella abortus virB operon, encoding the type IV secretion
system (52). In Shigella flexneri, IHF positively regulates virulence gene expression at multiple promoters, including the
virF, virB, and icsA promoters (47). Flagellum production in
enteropathogenic and enterohemorrhagic E. coli strains is repressed by IHF (69). IHF can act as a transcriptional regulator
by different mechanisms. In several cases, IHF produces a
DNA bend that enables the direct interaction of a distant,
DNA-bound transcriptional regulator with RNA polymerase
to enhance transcription (15). DNA bending by IHF can stimulate the recruitment of RNA polymerase to activate transcription by favoring the interaction of the ␣ subunit C-terminal
domain with upstream DNA UP elements (3). IHF binding can
also serve to lower the activation energy for open complex
formation (45). IHF typically acts as an architectural factor

The ability of pathogenic bacteria to modulate the expression of genes in response to environmental stimuli is widespread and critical for bacterial survival within specific niches.
Nucleoid-associated proteins, such as H-NS, integration host
factor (IHF), Fis, and HU play important roles in this adaptive
process. These proteins comprise a group of abundant DNAbinding proteins that condense the bacterial chromosome,
modulating its structure and influencing many cellular processes, such as DNA replication (51), site-specific recombination (5, 16), and transcription (35). The nucleoprotein complexes formed in response to environmental cues have both
negative and positive influences on transcription, and these
proteins function with one another and with gene-specific regulatory factors to fine tune gene expression.
The nucleoid-associated protein H-NS is an abundant global
regulator that influences various cellular processes (13, 14, 41).
H-NS binds DNA with relatively low sequence specificity but
instead has a preference for AT-rich segments with intrinsic
planar curvature (49, 68). Studies using chromatin immunoprecipitation-on-chip technology have identified the H-NS
binding regions over the Escherichia coli and Salmonella enterica serovar Typhimurium genomes (18, 32, 42, 44). Their
results demonstrate that H-NS binds to regions of high AT
content, including genes acquired by horizontal gene transfer.
Of interest was the finding that H-NS interacts with extensive
DNA stretches on pathogenicity islands and represses the transcription of the associated virulence genes. This discovery has
raised speculation that H-NS may function to silence foreign
DNA until dedicated transcription factors are able to relieve
H-NS repression (14). Recent studies have proposed that
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that leads to the correct promoter structure necessary for transcriptional regulation. An alternative mechanism of IHF activation is antirepression of H-NS-repressed promoters (63).
Virulence gene expression in the human enteric pathogen
Vibrio cholerae is dependent upon a complex transcriptional
cascade that is influenced by both specific regulators, such as
ToxR/S, TcpP/H, and ToxT, and global regulators, such as
cyclic AMP-cyclic AMP receptor protein and H-NS, in response to environmental stimuli (for reviews, see references 9
and 55). Production of the two main virulence factors, the
toxin-coregulated pilus (TCP) (60) and the cholera toxin (CT)
(23), is required for human colonization and causes the severe
watery diarrhea that is characteristic of the disease. Both of
these virulence factors are carried on genetic elements acquired by horizontal gene transfer that have a higher AT content (⬎60% AT rich) than the ancestral chromosome (52% AT
rich). The tcp genes are carried on the Vibrio pathogenicity
island (VPI), and the ctx genes are carried on the CT phage.
The expression of the tcp and ctx genes is transcriptionally
controlled in response to environmental stimuli by a regulatory
cascade, termed the ToxR virulence regulon, that involves proteins encoded within both the ancestral Vibrio genome and the
VPI. The cascade is initiated by two chromosomally encoded
proteins, AphA and AphB, functioning synergistically to activate transcription of tcpPH (25, 56). TcpP and TcpH (6, 20) are
transmembrane proteins encoded on the VPI that, along with
a second pair of transmembrane proteins, ToxR and ToxS (37,
38), activate transcription at the toxT promoter in a cooperative manner (21, 28). ToxT directly activates the expression of
many genes, including the tcp operon (7, 12, 22, 71), the ctx
operon (12), and the accessory colonization factor genes acfA
and acfD (46, 65). In addition, ToxT autoregulates its own
expression through activation of the tcpA promoter and
readthrough into toxT (70).
In addition to the specific regulatory proteins of the ToxR
virulence regulon mentioned above, the nucleoid-associated
protein H-NS has been shown to play an important role in V.
cholerae virulence gene expression (17, 27, 43). Mutation of V.
cholerae hns causes derepression of toxT, tcpA, and ctx expression to near-wild-type levels even in the absence of cognate
activator proteins (43). A variety of data indicate that H-NS
directly influences transcription at each of these promoters.
Thus, H-NS functions at multiple promoters within the cascade
to reduce virulence gene expression under particular environmental conditions.
In the present study, we show that, in contrast to H-NS, the
nucleoid protein IHF positively influences virulence gene expression in V. cholerae. Deletion of either the ihfA or the ihfB
gene decreased chromosomally encoded ctx-lacZ and tcpAlacZ promoter fusion expression and prevented TCP and CT
production. The same mutations had no effect on tcpP-lacZ or
toxT-lacZ fusions. Gel mobility shift assays and DNase I footprinting experiments with purified V. cholerae IHF demonstrate that IHF recognizes a putative IHF consensus site within
the tcpA promoter and introduces a bend upon binding. DNase
I footprinting at tcpA revealed that H-NS binding covers the
identified IHF consensus site as well as the ToxT site. In
addition, we determined that the dependence on IHF for optimal tcpA expression requires the presence of both H-NS and
ToxT.

IHF REGULATION OF tcpA EXPRESSION
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MATERIALS AND METHODS
Bacterial strains and growth. The V. cholerae and E. coli strains and plasmids
used in this study are listed in Table 1. Strains were maintained at ⫺70°C in
Luria-Bertani (LB) medium (36) containing 30% (vol/vol) glycerol. Antibiotics
were used at the following concentrations in LB medium: ampicillin (Amp), 100
g/ml; gentamicin, 30 g/ml; kanamycin (Kan), 45 g/ml; polymyxin B, 50 IU/ml;
and streptomycin, 1 mg/ml. 5-Bromo-4-chloro-3-indolyl-␤-D-galactopyranoside
(X-Gal) was used in LB agar at 40 g/ml (Sigma).
Construction of chromosomal ihf deletions. The ihfA subunit deletion was
constructed in pKAS32 (53) by PCR using primer HMEco (oligonucleotide
sequences are listed in Table 2) with HMNot1 and HMNot2 with HMXba. A
Kanr fragment was inserted between the two fragments at the NotI site, and the
resulting plasmid, pGKK158, was used for allelic exchange. The ihfB subunit
deletion construct was created in pKAS46 (53) by PCR using primer HBEco with
HBNotI and primer HBNot2 with HBXba. A Genr fragment was inserted between the two fragments at the NotI site, and the resulting plasmid, pGKK162,
was used for allelic exchange. Deletions were confirmed by PCR.
Expression plasmids. Plasmid pKAS161 was constructed by PCR amplifying a
1-kb fragment containing the ihfA subunit with primers HMEco and HMXba.
The resulting product was directly cloned into pBAD-TOPO (Invitrogen) and
sequenced.
The V. cholerae hns expression plasmid pEAS10 was constructed by PCR
amplifying the 414-bp hns gene from O395 chromosomal DNA by using HNS1
and HNS2. The resulting fragment was digested with NdeI and SapI and ligated
into similarly cut pTXB-1 to generate pEAS10. The nucleotide sequence was
confirmed by DNA sequencing.
Construction of IHF binding site mutations. The 21-bp deletion of the putative IHF consensus site in the tcpA promoter was constructed using primer pairs
H-Eco/Sap1B and ABgl2/Ear1T to amplify chromosomal sequences from O395.
The fragments were digested with SapI and EarI to produce seamless junctions,
followed by BglII and EcoRI digestion and ligation into pKAS32 to generate
pEAS9. The resulting plasmid was confirmed by sequencing. To construct four
base pair mutations (shown in Fig. 4C) in the most highly conserved residues of
the IHF consensus site, the primer pairs H-Eco/Sap2B and Ear3T/ABgl2 were
used to amplify O395 chromosomal DNA. After digestion as described above,
the fragments were ligated into pKAS32, generating p4PM-tcpA, and sequenced.
These mutations were introduced into the tcpA-lacZ fusion strain (MBN135) or
O395 by allelic exchange and subsequently confirmed by sequencing.
␤-Galactosidase assays. ␤-Galactosidase assays (36) were carried out after
overnight growth in LB medium with a starting pH of 6.5 at 30°C and shaking.
Due to TCP-mediated bacterial autoagglutination, the specific activities of
strains in the ctx-lacZ background were calculated using the protein concentration determined by a bicinchoninic acid procedure (Pierce) rather than using the
more standard optical density normalization method.
CT assays. GM1 ganglioside enzyme-linked immunosorbent CT assays (23)
were carried out on the supernatants of overnight cultures grown in LB medium
with a starting pH of 6.5 at 30°C and shaking.
Immunoblot analysis. Whole-cell protein extracts prepared from the overnight
cultures used for CT assays were subjected to sodium dodecyl sulfate-12.5%
polyacrylamide gel electrophoresis, transferred to a nitrocellulose membrane,
probed with an anti-TcpA antibody (59) or an anti-ToxT polyclonal antibody,
and visualized using an enhanced chemiluminescence detection system (Amersham).
Purification of the V. cholerae IHF heterodimer. Plasmids pEAS2 and pEAS3
were generated to overexpress the genes encoding the IHF␣ and IHF␤ subunits,
respectively. The ihfA gene was amplified from O395 chromosomal DNA by
using primers ihfA1 and ihfA2, digested with EcoRI and SphI, and ligated into
similarly cut pBAD22, creating pEAS2. The ihfB gene was amplified from O395
chromosomal DNA with the primer pair ihfB1/ihfB2, digested with EcoRI and
SphI, and ligated into pEAS1, creating pEAS3. pEAS1 was generated by ligating
the 50-bp ribosomal binding site from pBAD22 (NheI/SphI-digested fragment)
into pKAS178 (a pBAD33 Kmr derivative) to replace the pBAD33 ribosomal
binding site. This ensured that the translational efficiencies of ihfB from pEAS3
and ihfA from pEAS2 were comparable. The nucleotide sequences of both
constructs were confirmed by sequencing. V. cholerae O395 harboring both
pEAS2 and pEAS3 was grown overnight in 10 ml of LB at 37°C with shaking and
used to inoculate 2 liters of LB containing Amp/Kan. The culture was grown for
3 h, and arabinose was then added to give a final concentration of 0.1%. Following overnight incubation at 37°C with shaking, the V. cholerae IHF heterodimer was extracted as soluble protein as previously described (40). Briefly,
the culture was centrifuged, sonicated, and recentrifuged and the supernatant
was precipitated with 50% ammonium sulfate. After centrifugation, the resulting
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TABLE 1. Bacterial stains and plasmids used in this study

Strain or plasmid

Strains
V. cholerae
O395 Sm
CG842
KSK218
GK628
GK646
KSK618
GK630
GK652
MBN032
GK632
GK663
MBN135
GK648
GK650
ES23
ES24
MBN142
ES41
MBN148
ES42
MBN168
ES43
ES21
E. coli ER2566
Plasmids
pKAS32
pGKK158
pKAS46
pGKK162
pBAD-TOPO
pKAS161
pKAS178
pBAD22
pEAS1
pEAS2
pEAS3
pBlueScript
pEAS4
pEAS5
pBEND5
pEAS7
pEAS9
pTXB-1
pEAS10
p4PM-tcpA
pRH81

Characteristic(s)

Reference or source

Classical Ogawa; Smr
O395; ⌬lacZ
CG842; ctx-lacZ; Smr Cmr
KSK218; ⌬ihfA::kan
KSK218; ⌬ihfB::gen
CG842; tcpP-lacZ
KSK618; ⌬ihfA::kan
KSK618; ⌬ihfB::gen
CG842; toxT-lacZ1
MBN032; ⌬ihfA::kan
MBN032; ⌬ihfB::gen
CG842; tcpA-lacZ
MBN135; ⌬ihfA::kan
MBN135; ⌬ihfB::gen
MBN135; ⌬consensus at tcpA
MBN135; 4PM mutation in tcpA IHF consensus site
MBN135; ⌬toxT
MBN135; ⌬toxT ⌬ihfA::kan
MBN135; ⌬hns
MBN135; ⌬hns ⌬ihfA::kan
MBN135; ⌬toxT ⌬hns
MBN135; ⌬toxT ⌬hns ⌬ihfA::kan
O395; ⌬ihfA::kan

60
8
54
This
This
56
This
This
43
This
This
43
This
This
This
This
43
This
43
This
43
This
This

Expression strain; T7 RNA polymerase

New England Biolabs

pGP704; rpsL; Apr
pKAS32; ⌬ihfA::kan; Apr Kmr
pKAS32; Kmr
pKAS46; ⌬ihfB::gen; Kmr Gmr
Expression vector; Kmr
pBAD-TOPO; ihfA; Kmr
pBAD33; Kmr Cmr
Expression vector; Apr
pKAS178; RBS from pBAD22; Kmr
pBAD22; ihfA; Apr
pEAS1, ihfB; Kmr
Cloning vector; Apr
pBlueScript; 232-bp tcpA promoter fragment
pBlueScript; 360-bp tcpA promoter fragment
Vector for circular permutation assay; Apr
pBEND5; 66-bp tcpA IHF consensus site
pKAS32; 21-bp deletion including tcpA IHF consensus site (⌬consensus)
Expression vector for intein/chitin binding domain fusion; Apr
pTXB-1; hns Apr
pKAS32; tcpA IHF consensus 4-point mutations (4PM)
pBAD22; His6 toxT

53
This work
53
This work
Invitrogen
This work
24
19
This work
This work
This work
Stratagene
This work
This work
72
This work
This work
New England Biolabs
This work
This work
22

supernatant was precipitated with 70% ammonium sulfate and the pellet was
resuspended in 1 ml of TG (50 mM Tris [pH 7.4], 10% glycerol) containing 10
mM KCl. The protein was then dialyzed overnight against TG containing 10 mM
KCl, loaded onto a phosphocellulose column, and eluted with a KCl salt gradient
from 10 mM to 1.2 M in TG. The IHF-containing fractions were pooled, dialyzed
against a 25 mM NaH2PO4 (pH 5.5), 1 mM EDTA, 5% glycerol buffer, fractionated over a cation exchange Macro-Prep High S support (Bio-Rad) at pH
5.5, and developed with a linear gradient (75 to 800 mM) of NaCl in 25 mM
NaH2PO4 buffer. The fractions were analyzed on an 18% urea polyacrylamide
gel, and the IHF-containing fractions were pooled and further dialyzed against
25 mM NaH2PO4, 1 mM EDTA, 5% glycerol. The estimated purity of the IHF
heterodimer was 95% as determined by densitometry.
Purification of V. cholerae H-NS. H-NS was purified using the IMPACT-CN
system, which uses a cleavable chitin binding domain fused to the C terminus of
a protein for purification utilizing a chitin column (New England Biolabs). E. coli

work
work
work
work
work
work
work
work
work
work
work
work
work
work

strain ER2566, containing the hns expression plasmid pEAS10, was grown in LB
containing Amp at 37°C for 3 h, induced with 1 mM IPTG (isopropyl-␤-Dthiogalactopyranoside), and grown overnight at 16°C. The cells were collected by
centrifugation and resuspended in column buffer (20 mM Tris [pH 8.0], 500 mM
NaCl, 1 mM EDTA). The extract was sonicated and clarified by centrifugation at
14,000 rpm for 30 min in an SS34 rotor. The supernatant was then loaded onto
a chitin column equilibrated with column buffer to bind the fusion protein and
washed with 10 volumes of column buffer and high-salt column buffer (containing
1 M NaCl). Three volumes of cleavage buffer (column buffer containing 100 mM
dithiothreitol [DTT]) were added, and the column was incubated overnight at
4°C. H-NS was then eluted off the column with column buffer. The eluted protein
was dialyzed overnight in a solution of 20 mM Tris (pH 8.0), 1 mM EDTA, 5 mM
potassium glutamate, and 0.1 mM DTT. Glycerol was added to the protein to
10%, and the protein was stored at ⫺70°C. The final purity of H-NS was
estimated to be greater than 90% as determined by densitometry.
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TABLE 2. Oligonucleotides used in this study
Name

Sequencea

HMEco.........GATCGGAATTCCAGCGGTAGAGGCGATTGTG
HMNot1.......GATCGGCGGCCGCAAAACTTCCCTCAAAGCTAAG
HMNot2.......GATCGGCGGCCGCGACCGAGCAATAGACCACGC
HMXba ........GATCGTCTAGATTTAGCCCGAGCCACCATAG
HBEco..........GATCGGAATTCCGTGACCGTATCGAAGATGC
HBNot1 ........GATCGGCGGCCGCTAGTTTCCCTCTTCGAGTTG
HBNot2 ........GATCGGCGGCCGCTCTGAGTAAAGTTTGTTCAC
HBXba .........GATCGTCTAGATCTTGCTGGGCGCTACGATG
H-Eco ...........GATCGGAATTCCACGTTATCAAACATTGCCAG
Sap1B ...........GATCGGCTCTTCGCTTGTAATTTAATGCAAATAAAATGC
ABgl2............GATCGAGATCTGCTGTCGCATCAGCTGTTGC
Ear1T............GATCGCTCTTCGAAGTTGGCCTTTTTTTAGTGTC
Sap2B ...........GATCGGCTCTTCGACCTTTAAAGTAATTTAATGCAA
Ear3T............GATCGCTCTTCGGGTTTTGAAGTGAATAAGTTGGC
ihfA1.............GATCGGAATTCACCATGGCGCTCACAAAGGCCGAATTG
ihfA2.............GATCGGCATGCGTCTTATTTTTCGACTTTGATG
ihfB1 .............GATCGGAATTCACCATGACTAAGTCCGAACTGATAG
ihfB2 .............GATCGGCATGCGATTACAAGTTAACGCGTTCG
HNS1 ............GATCGCATATGGTAATGTCGGAAATCACTAAG
HNS2 ............GATCGGCTCTTCAGCACAGAGCGAATTCTTCCAGAGA
TCP-SAL .....GACTCGTCGACAATTTCGATCTCCACTCCGG
TCP-XHO....GTCAACTCGAGCATATTTATGTAACTCCACC
ctxP2 .............GATCGGAATTCTACCGGATTTTAATCACTTTG
ctxP1 .............GATCGGGATCCCATCAGGAGGTCTAGAATCTG
tcp1 ...............GACTCTCTAGAAGTGTCTGATTTATTTTGTG
tcp2 ...............GACTCGGATCCTTGCTGTGTTTTTTTATTTT
tcp7 ...............GATCGGAATTCATCCACGTAGGTGGGTATAG
tcp9 ...............GATCGGGATCCCATATTTATGTAACTCCAC
tcp12 .............GCATTTTATTTGCATTAAATTAC
tcp13 .............GACACTAAAAAAAGGCCAAC
a
All primer sequences are shown 5⬘ to 3⬘. Underlines indicate sequences
encoding relevant restriction sites, while substitutions are in bold.

Gel mobility shift assays. DNA fragments containing the putative IHF binding
sites in the promoter regions of the tcpA and ctx operons were generated by PCR
from V. cholerae O395 chromosomal DNA or from the pEAS9 or p4PM-tcpA
plasmid with the TCP-SAL (⫺226)/TCP-XHO (⫹78), TCP-SAL/tcp2 (⫺50),
tcp1 (⫺100)/TCP-XHO, or ctxP2 (⫺194)/ctxP1 (⫹118) oligonucleotide pair. IHF
gel mobility shift assays were carried out in a volume of 20 l containing
DNA-binding buffer (50 mM Tris [pH 7.4], 70 mM KCl, 1 mM EDTA, 1 mM
DTT, 100 g/ml bovine serum albumin, 5% glycerol), 10 ng of digoxigenin
(DIG)-labeled DNA, 1.5 g of calf thymus DNA, and purified IHF heterodimers. After incubation at 30°C for 15 min, protein-DNA complexes were
separated from free probes by electrophoresis on 5% nondenaturing polyacrylamide gels and transferred to nylon. H-NS gel mobility shift assays were carried
out in a volume of 20 l containing DNA-binding buffer (40 mM HEPES, 100
mM potassium glutamate, 10 mM magnesium aspartate, 0.022% NP-40, 100
g/ml bovine serum albumin, 10% glycerol), 10 ng of DIG-labeled DNA, 1 g of
calf thymus DNA, and purified H-NS. After incubation at room temperature for
20 min, protein-DNA complexes were separated by 5% nondenaturing polyacrylamide gel electrophoresis and transferred to nylon. DNA was visualized with
an anti-DIG detection kit (Roche), followed by enhanced chemiluminescence
detection.
DNase I footprinting. DNA fragments of 232 and 360 bp were generated from
the O395 tcpA promoter by amplification with the tcp7 (⫺282)/tcp2 (⫺50) or
tcp7/tcp9 (⫹78) primer pair. These fragments were ligated into pBlueScript
(Stratagene), generating pEAS4 and pEAS5, respectively. Fragments for labeling
were digested from pEAS4 and pEAS5 with EcoRI and BamHI. Strand labeling
was carried out essentially as described by Kovacikova and Skorupski (26).
Binding reactions were performed in a 6.5-l volume containing 33P-end-labeled
DNA, purified IHF or H-NS, and the corresponding binding buffer as described
above. After incubation at 30°C for 15 min, protein-DNA complexes were digested with 1 l of various dilutions of DNase I (Promega) for 5 min at 30°C. The
reactions were stopped by addition of 2 mM EGTA, followed by heat inactivation at 65°C for 10 min and then spot dialysis for 30 min against 10 mM Tris (pH
8.0), 0.1 mM EDTA. The reaction mixtures were then heated to 90°C for 5 min
in formamide loading buffer (Epicenter) and separated on a 6% acrylamide
sequencing gel with 1⫻ Tris-borate-EDTA. The gels were dried and visualized by
autoradiography.
Circular permutation assay. The ability of IHF to bend DNA at its binding site
was tested as described by Wu and Crothers (66). A 67-bp fragment containing
the IHF binding site was amplified with primers tcp12 and tcp13 and cloned into
the HpaI site of pBEND5 (72), generating pEAS7. The insert was confirmed by
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sequencing. Permutated DNA fragments were generated from pEAS7 by digestion with the enzymes listed in Fig. 5, and the resulting 190-bp fragments were
purified from polyacrylamide gels and labeled with DIG. A standard gel mobility
shift assay with purified IHF was performed on each fragment as described
above.

RESULTS
IHF positively regulates expression of the tcpA and ctx promoters. To assess the influence of IHF on the regulation of
virulence gene expression in V. cholerae, ⌬ihfA::kan and
⌬ihfB::gen mutants were constructed in the ctx-lacZ fusion
strain KSK218 (54). Under conditions known to induce virulence gene expression, LB with a starting pH of 6.5 at 30°C,
both ihf mutants showed fivefold reductions in ctx-lacZ expression (Fig. 1A). Since tcpA expression is coordinate with that of
ctx, the influence of the ihf mutations on a tcpA-lacZ fusion
strain, MBN135 (43), was assessed and expression was also
reduced approximately fourfold (Fig. 1A). These results show
that IHF plays a role in the positive activations of the ctx and
tcpA promoters. Expression of the ␣ subunit of IHF in pBADTOPO (pKAS161) in the ihfA mutant strain restored normal
ctx-lacZ and tcpA-lacZ expression, confirming that the decreased expression levels observed at these promoters were
due to the lack of functional IHF in the ⌬ihfA::kan strain
(Fig. 1B).
Introduction of the ⌬ihfA::kan mutation into wild-type O395
confirmed that the production of TCP and CT in V. cholerae is
dependent upon IHF. As observed in Fig. 2A, the ⌬ihfA::kan
mutant ES21 is considerably reduced for TcpA and CT production when grown under inducing conditions. In addition,
both of these products were restored with ihfA overexpression
from pEAS2 (Fig. 2A).
The influence of IHF on virulence gene expression could be
the result of a direct effect at the ctx and tcpA promoters, or the
effect could be indirect due to an influence of IHF at promoters further upstream in the virulence cascade, such as the
tcpPH, toxR, or toxT promoter. To address the IHF effect on
tcpPH, the ⌬ihfA::kan and ⌬ihfB::gen mutations were introduced into the tcpPH-lacZ strain KSK618 (56). The expression
of tcpPH was not influenced by either ihf mutation (data not
shown). Levels of ToxR, a member of the protein pair that
cooperates with TcpP/H to activate toxT expression, were also
unaffected by the ⌬ihfA::kan mutation, as detected by immunoblot analysis (data not shown). The expression of toxT is
influenced by two promoters, one that is TcpP/ToxR dependent, located immediately upstream of toxT, and one that is
ToxT dependent and initiates upstream of tcpA (see Fig. 8). To
determine the effect of IHF on toxT expression from the TcpP/
ToxR-dependent promoter, the ⌬ihfA::kan and ⌬ihfB::gen mutations were introduced into the toxT-lacZ strain MBN032,
which is lacking ToxT (43). Expression from this promoter was
not influenced by either ihf mutation (data not shown). To
address whether IHF influences toxT expression from the
ToxT-dependent promoter upstream of tcpA, a Western blot
analysis was performed to assess whether total ToxT levels
were altered in the ihfA mutant. As shown in Fig. 2B, ToxT
levels were lower in the ihfA mutant than in the wild type upon
growth to late log phase under inducing conditions. Additionally, when total toxT transcript from nonfusion backgrounds
was measured by quantitative real-time PCR from cultures
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FIG. 2. TcpA, CT, and ToxT production in O395 and the ihfA
mutant. Strains were grown overnight in LB medium with a starting pH
of 6.5 at 30°C with shaking. Western blot analysis with the anti-TcpA
(␣-TcpA) antibody (A) or ␣-ToxT polyclonal antibody (B) was performed with 16 g of total protein extract. CT represents the amount
of CT detected in the culture supernatant as measured by a GM1ganglioside enzyme-linked immunosorbent CT assay (A) (expressed in
ng/mg of protein). WT, wild type.

FIG. 1. Influence of IHF on ctx-lacZ and tcpA-lacZ expression.
(A) Wild-type (WT) (tcpA-lacZ or ctx-lacZ), ihfA (⌬ihfA::kan), or ihfB
(⌬ihfB::gen) mutants. (B) WT, ihfA, or ihfA mutants with the empty vector
pBAD-TOPO or the IHF␣ expression vector pIHFA (pKAS161). Cultures were grown overnight in LB medium with a starting pH of 6.5 at
30°C with shaking (those with plasmids contained 0.1% arabinose) and
assayed for ␤-galactosidase production. The values are the averages for at
least two independent experiments.

grown overnight under inducing conditions, toxT transcript
levels were decreased similarly to tcpA transcript levels in the
ihfA mutant compared to wild-type levels (data not shown).
The observation that IHF does not appear to influence expression from the TcpP/ToxR-dependent promoter and yet total
transcript levels (TcpP/ToxR-dependent and ToxT-dependent
toxT transcripts) were reduced in the ihfA mutant suggests that
IHF might have a direct effect on the ToxT-dependent promoter upstream of tcpA. The decreases in ctx expression and
CT production in this mutant are most likely due to reduced
toxT expression resulting from the influence of IHF at the tcpA
promoter. This is further supported by studies of IHF binding
at these promoters (see below).
Purified IHF from V. cholerae binds the tcpA promoter region between positions ⴚ226 and ⴚ50. Gel mobility shift assays were used to assess whether IHF directly binds to the
virulence gene promoter regions. Increasing amounts of purified V. cholerae IHF (180 and 360 nM) were incubated with 10
ng of ctx (C) or tcpA (A1) promoter fragments. IHF did not
bind the ctx fragment (C) but did bind the tcpA fragment (A1)
(Fig. 3), suggesting a direct role for IHF at the tcpA promoter
and not the ctx promoter. tcpP and toxT promoter fragments
also failed to bind IHF in gel mobility shift assays (data not
shown). These results are consistent with expression data that
suggest that IHF does not have a direct regulatory role at the
tcpP or toxT promoters.
To locate the IHF binding site within the tcpA promoter
region, smaller fragments (A2 and A3) were used to determine
where binding occurs. Two putative IHF consensus sites based
on the E. coli IHF consensus site WATCAANNNNTTR,
where W represents A or T and R represents A or G, are

present within the tcpA promoter. One site overlaps the ⫺35
region (5⬘-CATCTGTCAATTG), while the second is located
upstream and centered at position ⫺162 (5⬘-AATCATTTGA
ATT), about 80 bp upstream of the ToxT binding site (positions ⫺84 to ⫺41). IHF was capable of binding to the promoter
fragment containing the ⫺162 site alone (⫺226 to ⫺50) (A2),
whereas it was not capable of binding to the ⫺35 site alone
(⫺100 to ⫹78) (A3) (Fig. 3). Despite the presence of only one
shifted complex on the A1 fragment containing both putative
sites, it is formally possible that IHF binds the ⫺35 site only in
the presence of the ⫺162 site. This possibility was examined in
DNase I footprinting experiments where both sites were
present on the same fragment (see below). Notably, the DNA
surrounding the ⫺162 site from position ⫺200 to ⫺125 has
76% AT content. The high AT content, coupled with the
knowledge that the nucleoid-associated protein H-NS directly
represses tcpA expression (71) and itself preferentially binds
AT-rich DNA (18, 32, 42, 44), suggests that the region around
position ⫺162 may also be an H-NS binding site. Scanning of
this region for putative H-NS nucleation sites by use of the
10-bp consensus site identified by Lang et al. (29) revealed two
matches adjacent to the IHF consensus site (Fig. 4C, boxes),
further suggesting that IHF and H-NS could both bind this
region of the tcpA promoter.
IHF and H-NS binding sites overlap the ⴚ162 IHF consensus site. DNase I footprinting was used to determine if IHF
and H-NS bind the same ⫺162 region within the tcpA promoter. Radiolabeled fragments that spanned the tcpA promoter region from position ⫺282 to ⫺50 (IHF footprint) and
from position ⫺282 to ⫹78 (H-NS footprint) were generated,
incubated with increasing amounts of IHF (1.2 M and 2.4
M) and H-NS (1 M, 2 M, and 4 M), respectively, and
digested with DNase I as described in Materials and Methods.
The reaction mixtures were then subjected to electrophoresis
on a denaturing polyacrylamide gel. IHF protected a region
from position ⫺185 to ⫺126 on the top strand and a region
from position ⫺198 to ⫺136 on the bottom strand (Fig. 4A).
This protection overlapped the putative IHF consensus site at
position ⫺162 and the two putative H-NS nucleation sites, as
shown in Fig. 4C. DNase I-hypersensitive sites, a characteristic
of DNA bending, flank the IHF protection, suggesting that
IHF might be bending the tcpA promoter upon binding. IHF
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FIG. 3. Gel mobility shift assay for IHF binding to ctx and tcpA promoter DNA. The DIG-labeled promoter fragments of ctx from position
⫺194 to ⫹118 (C) and tcpA from position ⫺226 to ⫹78 (A1), ⫺226 to
⫺50 (A2), and ⫺100 to ⫹78 (A3) were incubated with purified IHF and
analyzed by a gel mobility shift assay. The first lane in each set has no
protein added, the second lane contains 180 nM IHF, and the third land
contains 360 nM IHF. The boxes labeled ⫺162 and ⫺35 represent putative IHF consensus sites on the tcpA promoter fragments.

did not protect the putative IHF consensus site at the ⫺35 site
on the longer (⫺282 to ⫹78) tcpA fragment that contained
both IHF consensus sites (data not shown). This suggests that
the putative IHF site at position ⫺35 is not bound by IHF even
in the presence of the ⫺162 site and that the single shifted
complex observed with the A1 fragment in Fig. 3 is IHF binding to the ⫺162 site alone.
H-NS binding was more widespread than IHF binding within
the tcpA promoter region. H-NS bound over the IHF binding
site at position ⫺162 and strongly protected at least part of the
ToxT binding site that spans from position ⫺84 to ⫺41 in the
promoter region (71) (Fig. 4B). This binding region has an AT
content ⬎70% similar to that of the IHF binding region. These
results suggest that H-NS binding overlaps the binding sites of
both activators, IHF and ToxT, at the tcpA promoter and could
act to block the binding of these activator proteins.
IHF binding induces bending of the DNA upstream of tcpA.
IHF has been shown to bend DNA in a number of systems
(61), and this property has been suggested to be central to its
activities (39, 50, 57). We used the circular permutation assay
of Wu and Crothers (66) to determine the ability of IHF to
bend 190-bp restriction fragments containing a 67-bp fragment
of the tcpA promoter region encompassing the IHF binding
site at different positions relative to the ends of the restriction
fragment, as shown in Fig. 5A. The bending assay is based on
the observation that differences exist in the migration of linear
and bent DNA fragments and that the electrophoretic mobility
of bent protein-bound DNA differs with the positioning of the
DNA-binding site relative to either end of the fragment. The
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more centrally located the bending site, the more retarded
the migration of the protein-DNA complex. Gel mobility shift
assays with each fragment in the presence of IHF were carried
out as described above. All free DNA migrated at the same
rate, suggesting that there was no intrinsic bend in the DNA.
Mobility upon incubation with IHF was slowest when the IHF
binding site was centrally located (EcoRV) and maximal when
the site was closest to the end of the fragment (BglII and
BamHI). These results are consistent with the center of the
bend being located at the IHF binding site. Migration of the
fragments bound by IHF was measured from the well, and
the bending angle was calculated to be 120° by the method of
Thompson and Landy (61).
The influence of IHF consensus site mutations on IHF binding and tcpA expression. The IHF consensus site was altered in
order to disrupt IHF binding and activity at the tcpA promoter.
The first binding site mutation, termed ⌬consensus, was a
21-bp deletion that included the 13-bp IHF consensus site (Fig.
4C). The second, termed 4PM, was the introduction of 4-basepair changes in the most highly conserved consensus site residues, in which the TCA and the second-to-last T were
changed to GGT and G, respectively (Fig. 4C). Fragments of
the tcpA promoter region from position ⫺226 to ⫹78 containing these mutations were assessed for their effects on IHF
binding in gel mobility shift assays as described above. IHF did
not shift fragments containing the ⌬consensus or the 4PM
mutation (Fig. 6A). These results suggest that this site is essential for IHF binding. These mutations were then assayed for
their effects on tcpA transcription by integration into the tcpAlacZ background. Contrary to what was expected, neither the
⌬consensus nor the 4PM mutation mimicked an ihf mutant in
its effect on tcpA expression. Rather than the 4-fold decrease
seen previously in the ihf mutants, the promoter IHF consensus mutations caused only a 1.6-fold decrease in tcpA-lacZ
expression (data not shown). In addition, TcpA protein production was similar to wild-type levels when these mutations
were placed in the otherwise wild-type O395 background (data
not shown). This result suggests that the mechanism of IHF
activation at this site may be more complicated than simply
binding to the IHF consensus site.
H-NS binding to the IHF consensus mutations in gel mobility shift assays. One of the mechanisms by which IHF can
regulate transcription is alleviation of H-NS-mediated repression of transcription (63, 64). Based on the idea that IHF can
act as an antirepressor and given the DNase I protection data
that show overlapping H-NS and IHF sites, we chose to investigate whether the IHF consensus site mutations affected H-NS
binding to the tcpA promoter fragments. Gel mobility shift
assays were performed with wild-type and mutant tcpA promoter fragments from position ⫺226 to ⫹78 with increasing
amounts of H-NS (Fig. 6B). At low concentrations of H-NS,
two shifted bands occurred with the wild-type fragment, a
result consistent with our DNase I protection determination
that showed multiple H-NS binding sites within this promoter
region. The wild-type fragment was completely shifted in the
presence of 320 nM H-NS, whereas fragments containing the
⌬consensus and 4PM mutations were not fully shifted at 320
nM H-NS. These results suggest that the IHF consensus site
within the tcpA promoter not only is critical for IHF binding
but also contributes to optimal H-NS binding. The reduced
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FIG. 4. DNase I protection by IHF and H-NS at the tcpA promoter. The top and bottom strands of the tcpA promoter fragments were incubated
with increasing amounts of IHF (1.2 and 2.4 M) (A) or H-NS (1, 2, and 4 M) (B) and treated with DNase I. (A) IHF protection from DNase
I on a promoter fragment from position ⫺282 to ⫺50 is shown with hatched bars. Arrows designate sites that were hypersensitive to DNase I
treatment. NP, no protein. (B) H-NS protection on a promoter fragment from position ⫺282 to ⫹78 is shown with black bars to the right. On the
left, the hatched bars designate the IHF consensus site and the gray boxes designate ToxT binding sites. (C) tcpA promoter sequence from position
⫺200 to ⫺125. Black bars designate the IHF protection on the top and bottom strands, and the IHF consensus site within the protected region
is in bold and aligned with the E. coli consensus site below. W, A/T; R, A/G; N, any nucleotide. The 21 bp that were deleted in the ⌬consensus
mutation are marked above the sequence. The four base pair mutations that were incorporated into the consensus site are designated 4PM below
the consensus alignment. Boxes indicate putative H-NS nucleation sites with seven matches to the 10-bp H-NS consensus site (29).

H-NS binding in the ⌬consensus and 4PM mutants may
thereby serve to decrease repression of the tcpA promoter and
partially alleviate the requirement for IHF. The ⌬consensus
promoter mutation deletes 5 of the 10 bp that comprise the
second putative H-NS high-affinity nucleation site (Fig. 4C)
and could function to disrupt H-NS nucleation and polymerization from this site.
Competitive gel mobility shift assays were performed between IHF and H-NS on the tcpA promoter region to examine
the effect of adding either protein to prebound DNA complexes of the other. The DNA was incubated with the lowest
concentrations of H-NS or IHF (320 or 420 nM, respectively)
that gave a complete shift of the free DNA. After 15 min at
30°C, increasing amounts of IHF or H-NS, respectively, were
added and incubation was continued for an additional 15 min.

Addition of either 120 or 240 nM of IHF to a prebound H-NS
fragment did not influence H-NS binding. However, addition
of 420 nM IHF resulted in displacement of H-NS from the
DNA and a shift to a predominately IHF-DNA complex. Addition of 160 to 320 nM H-NS to a prebound IHF-DNA fragment did not significantly influence the IHF-DNA complex.
These results suggest that IHF effectively displaces H-NS from
the tcpA promoter fragment and that, once bound, IHF can
essentially prevent H-NS binding.
Interplay of IHF, H-NS, and ToxT in the regulation of tcpA
expression. It is known that H-NS represses tcpA transcription.
It has been shown that IHF alleviates H-NS repression at the
bacteriophage Mu early (Pe) promoter and at the virB promoter in Shigella flexneri (47, 63). In an attempt to establish
whether IHF functions as an antirepressor at the tcpA pro-
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FIG. 5. Bending of the tcpA promoter DNA by IHF as determined by a circular permutation assay. (A) Diagram of 190-bp
linear probes produced by digestion of plasmid pEAS7 (pBEND5tcpA) with five restriction enzymes. The probes contain the IHF
consensus site (hatched box) within a 67-bp tcpA promoter fragment (⫺193 to ⫺127) (black box) at various positions relative to the
ends of the fragments. (B) Circular permutation analysis was performed on the tcpA IHF binding site with purified IHF. Each fragment was incubated without protein or with 180 nM IHF and
analyzed by a gel mobility shift assay. The bending angle, ␣, was
determined to be 120° using the equation (M/E) ⫽ cos(␣/2),
where M is the relative migration of the fragment with the bend
center in the middle and E is the relative migration of the fragment
with the bend center at the end (61).

moter, we investigated expression levels in strains harboring
wild-type or mutant copies of hns and ihfA. Cultures of the
tcpA-lacZ strains MBN135 (wild type), GK648 (ihfA::kan),
MBN148 (⌬hns), and ES42 (ihfA::kan ⌬hns) were grown overnight in LB with a starting pH of 6.5 at 30°C, and ␤-galactosidase activity was measured. As was previously described by
Nye et al. (43), the level of tcpA-lacZ expression in the absence
of hns (MBN148) was increased about 1.5-fold compared to
the wild-type (MBN135) level (Table 3). In the absence of hns
(MBN148), there was no further effect of deleting ihf on tcpAlacZ expression, suggesting that the ihf mutation is epistatic to
the hns mutation at the tcpA promoter. Furthermore, deleting
hns has a much greater derepressive effect on tcpA-lacZ expression in the absence of ihfA than when ihfA is present
(501% versus 145%) (Table 3). This suggests that IHF counteracts H-NS repression at tcpA.
In an attempt to determine if IHF-mediated activation at the
tcpA promoter is ToxT dependent, we investigated expression
levels in strains harboring wild-type or mutant copies of toxT
and ihfA. Cultures of the tcpA-lacZ strains MBN135 (wild
type), GK648 (ihfA::kan), MBN142 (⌬toxT), and ES41 (ihfA::
kan ⌬toxT) were grown overnight in LB with a starting pH of
6.5 at 30°C, and ␤-galactosidase activity was measured. As
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previously described by Hulbert and Taylor (22), there is a loss
of tcpA-lacZ expression in the absence of toxT (MBN142)
compared to that in a toxT-containing strain (MBN135) (Table
3). There was no further loss of tcpA-lacZ expression in the
ihfA toxT double mutant (ES41) compared to that in the toxT
mutant alone, suggesting that the positive effect of IHF at tcpA
requires ToxT. Furthermore, there was no affect of the ihf
mutant in an hns toxT background (MBN168) (Table 3). Taken
together, these results suggest that the IHF effect on tcpA
expression requires the presence of the repressor H-NS and
the activator ToxT.
Given that toxT expression is higher in an hns mutant due
to derepression (43) and that the ihf effect requires the
presence of ToxT, it is possible that the level of ToxT within
the cell determines the necessity for IHF at tcpA. We therefore examined the effect of overexpressing toxT in the
ihfA::kan background to determine if higher levels of ToxT
could overcome the role of IHF in activation. Wild-type
O395 or the O395 ihfA mutant ES21, harboring an empty
vector or the toxT overexpression vector pRH81, was grown
with or without arabinose to regulate toxT expression. Total
proteins were extracted, separated, and subjected to Western blotting. The levels of ToxT were slightly reduced in the
ihfA mutant strain compared to wild-type levels when toxT
was not induced from the plasmid (Fig. 7), consistent with
Fig. 2B. In addition, as seen in Fig. 2A, there is a drastic
reduction in TcpA levels in the ihfA mutant compared to
wild-type levels, despite this modest difference in ToxT levels. In the wild-type strain, overexpression of toxT did not
detectably increase TcpA production (Fig. 7). However,
TcpA was restored to near-wild-type levels upon overexpression of toxT in the ihf mutant. These results suggest that
if ToxT levels are sufficiently high, IHF is not essential for
maximal TcpA production. ToxT levels accumulate during
exponential growth but decline in stationary phase (data not
shown). IHF may be necessary when ToxT levels are low
(early exponential phase and stationary phase under virulence gene-inducing conditions) to facilitate ToxT binding
and activation at tcpA by overcoming some H-NS repression
and/or altering promoter structure to facilitate ToxT binding. Similar to E. coli IHF (1), V. cholerae IHF is produced
throughout the growth curve (under both virulence-inducing
and -noninducing conditions), but levels are maximal in
stationary phase (data not shown). This is consistent with a
role for IHF in facilitating ToxT-mediated activation of tcpA
when ToxT levels are low.
DISCUSSION
In the V. cholerae El Tor strain N16961, McLeod et al. have
found that, as in E. coli and Salmonella strains (2, 33), over 100
genes are differentially regulated in an ihfA mutant (34). In the
work presented here, we show that IHF positively influences
the expression of virulence genes in the V. cholerae classical
O395 strain. The introduction of the ihfA::kan and ihfB::gen
alleles into the tcpA-lacZ (MBN135) and ctx-lacZ (KSK218)
fusion strains resulted in a four- to fivefold reduction in the
expression of lacZ and prevented TCP and CT production. A
reduction in expression was not observed at the TcpP/ToxRdependent toxT promoter immediately upstream of the toxT
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FIG. 6. Mutations in the tcpA IHF consensus site alter IHF and H-NS binding. Mutations in the tcpA promoter were constructed to disrupt
IHF binding. The wild-type (WT) and mutant promoter fragments (⌬consensus and 4PM) from position ⫺226 to ⫹78 were incubated in the
absence of protein or with 180 nM IHF (A) or 80, 160, 250, or 320 nM H-NS (B) and analyzed by a gel mobility shift assay. (C) Competitive gel
mobility shift assay between H-NS and IHF on the wild-type promoter fragment. Lane 1, no protein added. Lane 2, 320 nM H-NS; lane 3, 420 nM
IHF. Lanes 4 to 6, 320 nM H-NS and 120 nM (lane 4), 240 nM (lane 5), and 420 nM (lane 6) IHF. Lanes 7 to 9, 420 nM IHF and 160 nM (lane
7), 250 nM (lane 8), and 320 nM (lane 9) H-NS.

gene (Fig. 8). However, the observation that the levels of ToxT
protein in the ihfA mutant were lower than those in the wild
type suggests that IHF might exert its effects at the ToxTdependent promoter upstream of tcpA that also influences toxT
expression. A direct role for IHF at the tcpA promoter was
demonstrated by the ability of the purified protein to bind to a

site centered at position ⫺162 in gel mobility shift and DNase
I footprinting assays. In addition, the protein was found to
bend the DNA 120°. Since IHF did not appear to bind to the
ctx promoter, these results suggest that the IHF effect on ctx

TABLE 3. Effect of IHF on expression of the tcpA-lacZ fusion in
wild-type, hns, toxT, and hns toxT strains
Strain

␤-Galactosidase activity (%)a
With ihfA

MBN135
MBN148
MBN142
MBN168

Without ihfA

(wild type) 18,591 ⫾ 520 (100) 4,890 ⫾ 270 (100)
(hns)
26,956 ⫾ 750 (145) 24,528 ⫾ 526 (502)
(toxT)
331 ⫾ 27 (1.8)
355 ⫾ 15 (7.3)
(hns toxT)
1,475 ⫾ 84 (7.9)
1,770 ⫾ 93 (36.2)

Fold
change

3.8
1.1
1.1
1.2

a
␤-Galactosidase activities (in Miller units) are shown for each strain and
expressed as percentages of the wild-type level. The values are the averages for
at least two independent experiments.

FIG. 7. Overexpression of toxT in the ihfA mutant background.
Strains were grown overnight in LB medium with a starting pH of 6.5 at
30°C with shaking and with the addition of 0.1% arabinose where indicated. Western blot analysis with anti-ToxT (␣-ToxT) and ␣-TcpA antibodies was performed with 16 g of total protein extract. WT, wild type.
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FIG. 8. Schematic of the transcriptional regulation of V. cholerae tcpA, toxT, and ctx expression. (A) OFF/INITIAL: H-NS represses gene
expression at multiple promoters within the ToxR regulon, including tcpA to -F, toxT, and ctx. H-NS binding in the tcpA promoter region overlaps
the IHF consensus sequence at position ⫺162 as well as the ToxT binding site spanning from position ⫺84 to ⫺41. (B) ON: After a transition to
virulence-inducing conditions, ToxR/S and TcpP/H in the inner membrane cooperate at the toxT promoter to activate toxT expression (TcpP/ToxR
dependent). ToxT-mediated activation of tcpA-toxT is facilitated by IHF binding, bending of the DNA, and displacement of H-NS, allowing for
greater accessibility of ToxT to its binding site. As ToxT levels accumulate, full activation of tcpA to -F, toxT, and ctx expression occurs.

expression is indirect due to lowered toxT expression driven
from the ToxT-dependent promoter upstream of tcpA.
A direct role for H-NS in the repression of tcpA expression
has previously been described (43, 71). Here, we show direct
binding of H-NS to the tcpA promoter by gel mobility shift
assays and DNase I footprinting. H-NS protection covered the
IHF binding site (position ⫺162) as well as the ToxT binding
site (which spans from ⫺84 to ⫺41) (Fig. 8A). Genetic studies
of tcpA-lacZ expression in strains harboring wild-type or mutant copies of ihfA, hns, or toxT showed that activation by IHF
appears to occur only when both H-NS and ToxT are present;
the ihfA mutation is epistatic to the hns and toxT mutations.
The functional dependence of IHF on H-NS and ToxT at tcpA,
along with the observed overlapping binding sites of these
proteins, suggests a possible model whereby IHF functions as
an antirepressor at this promoter. This is further supported by
the binding studies that show that IHF can displace H-NS from
the tcpA regulatory region and, once bound, occlude H-NS
binding.
As proposed in Fig. 8A, under noninducing conditions,
H-NS binds directly to the tcpA promoter covering the IHF
consensus sequence at position ⫺162 as well as the ToxT
binding site (spanning from ⫺84 to ⫺41), thereby repressing

the transcription of tcpA to -F. H-NS also appears to directly
repress toxT and ctx expression (43, 71). Under inducing conditions (Fig. 8B), ToxT levels from the TcpP/ToxR-dependent
promoter increase due to cooperation between ToxR/S and
TcpP/H in the inner membrane. Activation of the ToxT-dependent tcpA-toxT transcript is facilitated by binding of IHF to
the site centered at position ⫺162 that introduces a bend in the
promoter that partially displaces H-NS from the DNA. This
allows greater accessibility of ToxT to its binding site, resulting
in transcriptional activation of the tcpA to -F genes as well as
toxT. The subsequent increase in ToxT protein levels permits
full activation of tcpA to -F and ctx expression. In the absence
of IHF, we propose that under inducing conditions, the increased levels of ToxT from the TcpP/ToxR-dependent promoter are insufficient to fully overcome H-NS repression, and
thus, expression of tcpA to -F, toxT, and ctx is not induced to
maximal levels.
Consistent with this model is the finding that loss of the IHF
protein results in a fourfold reduction in tcpA expression,
whereas disruption of the IHF binding site by introduction of
the ⌬consensus or 4PM mutation, both of which alter IHF and
H-NS binding, causes only a small reduction in tcpA expression. Because the IHF and H-NS binding sites overlap, these
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promoter mutations phenotypically negate each other by simultaneously decreasing tcpA expression due to a reduction in
IHF-mediated activation and increasing tcpA expression due to
reduced H-NS repression. The hypothesis that IHF functions
as an antirepressor at the tcpA promoter is also supported by
the finding that IHF is not required upon overexpression of the
primary activator ToxT.
There are a number of reports of site-specific DNA-binding
proteins acting as H-NS antagonists by displacing H-NS from
common or adjacent binding sites. For example, H-NS is displaced by VirB binding at the icsB promoter in S. flexneri (62),
LeuO binding at the ompS1 promoter in S. enterica (11), and
SlyA binding to two distal SlyA/H-NS binding sites at hlyE in E.
coli K-12 (31). At the yjjQ-bglJ promoter in E. coli, LeuOinduced DNA looping is proposed to prevent H-NS oligomerization along the promoter (58). Similarly, IHF may function at
tcpA to displace H-NS from their overlapping binding site, and
the bend introduced upon IHF binding may prevent oligomerization along the promoter. A role for IHF in overcoming
H-NS repression at the early promoter (Pe) of bacteriophage
Mu has already been established (63). The Pe promoter of
bacteriophage Mu appears to be specifically inhibited by the
binding of H-NS to the promoter region. Binding of IHF to the
upstream site within the Pe promoter results in direct stimulation of the promoter and also interferes with the formation of
DNA-protein complexes between H-NS and Pe, thereby counteracting H-NS repression of this promoter. IHF also alleviates
H-NS repression at the virB promoter in S. flexneri (47). In this
example, IHF binding does not overlap the H-NS binding site
as in the case of the Pe promoter of Mu but is believed to
generate a conformational change in the DNA from an upstream location that facilitates the binding of the AraC-like
activator VirF, which itself overcomes H-NS repression. Similarly, ToxT appears to function, at least in part, to alleviate
H-NS repression at the tcpA promoter, in addition to its role as
an activator, since there is less H-NS repression of tcpA in the
presence of ToxT than in its absence (1.4-fold [wild type versus
⌬hns] versus 4.5-fold [⌬toxT versus ⌬toxT ⌬hns]).
Many bacterial pathogens have acquired virulence genes by
horizontal gene transfer, and it has been suggested that gene
silencing by H-NS allows the newly acquired genes to be integrated into regulatory networks, like the ToxR regulon in V.
cholerae, over time without initially negatively affecting the
fitness of the recipient bacterium (14). Enteric bacteria, like V.
cholerae, encounter multiple environmental stimuli both inside
and outside the human host. It is not surprising, therefore, that
bacteria have evolved complex regulatory systems to overcome
H-NS silencing and respond to a range of environmental inputs. As far as we know, the primary role of TCP and CT is in
human infection. The role of the global regulators H-NS and
IHF in infection has been hard to define due to their pleiotropic effects on transcription and the growth defects associated
with their loss. It is likely that H-NS and IHF function to
modulate the topology of the promoters on which the more
specific regulators, like ToxT, can act to optimize virulence
gene expression in V. cholerae. Using microarray analysis, Xu
et al. observed that hns is one of the most highly expressed V.
cholerae genes in vitro and in the rabbit ileal loop model of V.
cholerae infection (67). Additionally, Ghosh et al. (17) reported that H-NS represses ctx and tcpA expression in vivo
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(17). This group saw that the in vivo expression levels of ctx and
tcpA were increased in an hns mutant 8 h after infection of the
rabbit ileal loop. In addition, they noted that CT production
was about 2.5-fold greater in the hns mutant than in the wildtype O395 strain. These data demonstrate that H-NS is highly
expressed and active as a repressor at the ctx and tcpA promoters in this in vivo model. Proper colonization most likely
requires a mechanism to counteract some of this H-NS repression in order to achieve optimal virulence gene expression and
cause disease. Yu and DiRita (71) showed that ToxT-mediated
activations of the ctx and tcpA promoters are mechanistically
distinct. At ctx, ToxT has a higher affinity for its binding site
than it does at tcpA (71). However, Lee et al. have shown that
during infection, maximal tcpA expression occurs before maximal ctx expression (30). This is likely due, in part, to the
greater H-NS repressive effect on ctx expression than on tcpA
expression (43, 71). The differential expression might also be
due to the action of IHF at tcpA that could serve to lower the
threshold level of ToxT that is required to activate tcpA expression despite the lower affinity of ToxT for its binding site at
this promoter. Further analysis of the molecular interactions
between IHF, H-NS, and ToxT at the tcpA promoter will provide additional insights into the mechanism by which these
proteins interact to influence the later steps in the cascade that
regulates virulence gene expression in V. cholerae.
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